Monday, 16 September 2019

Pharma News

  • Lupin gets FDA nod for anti-depression generic

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Mumbai: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals has received final approval for its Escitalopram tablets (Escitalopram oxalate) 5mg, 10mg, and 20mg, from t...Read more

  • Teva launches generic of cancer drug Temodar in US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: Israel-based Teva Pharmaceutical and US-based Perrigo have launched generic version of cancer drug Temodar (temozolomide) in US. Teva will manufacture, market and distribute the...Read more

  • Bionomics cancer trial shows +ve results

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

    Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its cancer drug candidate BNC105 in women with ovarian cancer. After com...Read more

  • New drug slows cancer significantly

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dramatic and rapid effects on prostate cancer, which had already spread...Read more

  • Shionogi launches London headquarter

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

  • Tetraphase antibiotic gets FDA QIDP designation

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candidate, eravacycline, as a Qualified Infectious Disease Product (QIDP).QI...Read more

  • Astellas, Merck enter co-promotion deal in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreement for ipragliflozin L-proline, a SGLT2 inhibitor, in Japan. Earlier ...Read more

  • BGI-Shenzhen extends tender offer for Complete Genomics

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its all cash tender offer to purchase all outstanding shares of common s...Read more

  • Astellas, UCB announce approval of Cimzia in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: Astellas Pharma and UCB announced that UCB Japan has received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cimzia (INN;certolizumab pego...Read more

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • Frost & Sullivan awards life science leaders

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Mumbai: The 4th Annual Frost & Sullivan India Healthcare Excellence Awards 2012, were held in Mumbai to recognize companies that showed innovative growth strategies and solutions in the...Read more

  • Biostar signs another $3 mn military contract within a month

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to manufacture and supply Xijing Hospital with five additional drugs. Spec...Read more

  • FDA warns Genentech researcher for trial data validity

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular degeneration treatment, for failing to follow the protocol and maintai...Read more

  • Medigene, SynCore expand deal for Veregen

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and supply contract into new re...Read more

  • Ranbaxy may fire 1/3rd of its global sales staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of the job cuts expected to be in the US, according to a report by Busi...Read more

  • Aus, NZ progress on joint regulatory agency

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic Products Agency (ANZTPA) implementation ministerial council in a con...Read more

  • Now 9-yr-old girls can use Cervarix for cancer

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer caused by Human Papillo...Read more

  • Hiring freeze in pharma industry

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

    New Delhi: The overall economic crunch has resulted in companies adopting a cautious approach in their hiring plans., a major job site in India, in its survey on the pharma secto...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls